Official Publications Merck & Co., Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 07:42:21 18/06/2026 pm IST			5-day change	1st Jan Change
112.58 ^USD	-2.48%		-5.92%	+7.93%

05:36pm	Merck Receives U.S. FDA Approval for Expanded Indication of CAPVAXIVE Pneumococcal 21-Valent Conjugate Vaccine in Children and Adolescents Aged 2 Through 17 At Increased Risk for Pneumococcal Disease	CI
04:52pm	Merck Says FDA Approved Capvaxive in High-Risk Pediatric Patients	MT

04/05	SEC Filing 10Q-1	CO
30/04	Slide show Q1	CO
30/04	1st quarter results	CO
30/04	SEC Filing 8K	CO
08/04	Proxy Statments	CO
24/02	SEC Filing 10K	CO
03/02	Slide show results	CO
03/02	Annual results	CO
03/02	SEC Filing 8K	CO
27/01	Dividends	CO
07/01	Acquisition	CO
19/12	Business information	CO
05/11	SEC Filing 10Q-3	CO
30/25/30	3rd quarter results	CO
30/25/30	Slide show Q3	CO
30/25/30	SEC Filing 8K	CO
05/25/05	SEC Filing 10Q-2	CO
29/25/29	1st-half-year results	CO
29/25/29	SEC Filing 8K	CO
22/25/22	Dividends	CO
27/25/27	Dividends	CO
27/25/27	Shareholders meeting voting results	CO
02/25/02	SEC Filing 10Q-1	CO
24/25/24	Slide show Q1	CO
24/25/24	1st quarter results	CO